COVID-19 viral disease. Coronavirus infection, unspecified
Conditions
Interventions
Intervention 1: Intervention group: Dried powder of ZAX.1400.C05, made in the laboratory of medicinal plants of Fasa University of Medical Sciences, based on plant flavonoids, in the form of capsules,
Sponsors
Fasa University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Definitive diagnosis of COVID-19 disease by laboratory diagnostic kit from patient sputum Patient hemoglobin saturation (SPO2) between 85% and 93% in patients Detection of lung involvement by CT scan in patients The number of breaths per minute is between 25 and 30 in patients
Exclusion criteria
Exclusion criteria: History of allergies to herbal products Pregnancy and lactation Existence of liver and kidney diseases Inability of the patient to receive oral medication
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical signs. Timepoint: daily. Method of measurement: Evaluation form (questionnaire).;(VAS) Visual Analogue Scale. Timepoint: daily. Method of measurement: check list.;ESR (Erythrocyte sedimentation rate). Timepoint: Zero and fourteen days after the start of the intervention. Method of measurement: Standard sedimentation rate method.;C-Reactive Protein – CRP. Timepoint: Zero and fourteen days after the start of the intervention. Method of measurement: Autoanalyzer.;Liver enzymes SGOT, ALT, SGPT. Timepoint: Zero and fourteen days after the start of the intervention. Method of measurement: Autoanalyzer.;Renal indicators BUN, Creatinine. Timepoint: Zero and fourteen days after the start of the intervention. Method of measurement: Autoanalyzer. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of hospitalization. Timepoint: daily. Method of measurement: check list.;Mortality. Timepoint: daily. Method of measurement: check list. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAmin Dakhili Ardestani
Fasa University of Medical Sciences
Outcome results
None listed